» Articles » PMID: 12810485

Increased Risk of Late Posttraumatic Seizures Associated with Inheritance of APOE Epsilon4 Allele

Overview
Journal Arch Neurol
Specialty Neurology
Date 2003 Jun 18
PMID 12810485
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Late posttraumatic seizures are a common complication of moderate and severe traumatic brain injury. Inheritance of the apolipoprotein E (APOE) epsilon4 allele is associated with increased risk of Alzheimer disease, progression to disability in multiple sclerosis, and poor outcome after traumatic brain injury.

Objective: To determine whether inheritance of APOE epsilon4 is associated with increased risk of developing late posttraumatic seizures.

Design: Prospective study.

Setting: Neurosurgical service at an urban level I trauma center.Patients Patients admitted with a diagnosis of moderate and severe traumatic brain injury were enrolled.

Methods: Six months after injury, patients were contacted to determine functional outcome (according to the Glasgow Outcome Scale-Expanded [GOS-E]) and the presence of late posttraumatic seizures. Genotype at the APOE locus was determined by restriction fragment length polymorphism analysis.

Results: DNA and outcome information was obtained from 106 subjects. Six months after injury, 31 (29%) had a poor outcome (GOS-E score, 1-4), 47 (44%) had an intermediate outcome (GOS-E score, 5-6), and 28 (26%) had a favorable outcome (GOS-E score, 7-8). Twenty-one patients (20%) had at least 1 late posttraumatic seizure. The relative risk of late posttraumatic seizures for patients with the epsilon4 allele was 2.41 (95% confidence interval, 1.15-5.07; P =.03). In this cohort, inheritance of APOE epsilon4 was not associated with an unfavorable GOS-E score 6 (P =.47).

Conclusions: Inheritance of the APOE epsilon4 allele is associated with increased risk of late posttraumatic seizures. In this cohort, this risk appears to be independent of an effect of epsilon4 on functional outcome. A better understanding of the molecular role of APOE in neurodegenerative diseases may be helpful in developing antiepileptogenic therapies.

Citing Articles

Quality of Life Following Traumatic Brain Injury in Iraqi Patients.

Al-Azzaw U, Al-Ameri L Ethiop J Health Sci. 2025; 34(2):149-158.

PMID: 39980734 PMC: 11837779. DOI: 10.4314/ejhs.v34i2.6.


Polygenic Risk of Epilepsy and Poststroke Epilepsy.

Clocchiatti-Tuozzo S, Rivier C, Misra S, Zelano J, Mazumder R, Sansing L Stroke. 2024; 55(12):2835-2843.

PMID: 39502073 PMC: 11653790. DOI: 10.1161/STROKEAHA.124.047459.


Post-Traumatic Epilepsy: Observations from an Urban Level 1 Trauma Center.

Kotas D, Zhao H, Turella J, Kasoff W Neurol Int. 2024; 16(4):845-852.

PMID: 39195565 PMC: 11357076. DOI: 10.3390/neurolint16040063.


Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis.

Petersen S, Okolicsanyi R, Haupt L Cell Mol Neurobiol. 2024; 44(1):30.

PMID: 38546765 PMC: 10978659. DOI: 10.1007/s10571-024-01463-8.


Prominent genetic variants and epigenetic changes in post-traumatic stress disorder among combat veterans.

Baghaei A, Zoshk M, Hosseini M, Fasihi H, Nassireslami E, Shayesteh S Mol Biol Rep. 2024; 51(1):325.

PMID: 38393604 DOI: 10.1007/s11033-024-09276-0.